ADB-FUBINACA
ADB-FUBINACA
N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide, N-[1-(aminocarbonyl)-2,2-dimethylpropyl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide |
|
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide | |
Synthetic cannabinoids | |
Synthetic cannabinoid receptor agonists |
|
|
InChI=1S/C21H23FN4O2/c1-21(2,3)18(19(23)27)24-20(28)17-15-6-4-5-7-16(15)26(25-17)12-13-8-10-14(22)11-9-13/h4-11,18H,12H2,1-3H3,(H2,23,27)(H,24,28)
|
ZSSGCSINPVBLQD-UHFFFAOYSA-N
|
|
O=C(C1=NN(CC2=CC=C(F)C=C2)C3=C1C=CC=C3)NC(C(C)(C)C)C(N)=O
|
|
C21H23FN4O2 | |
382.4313 g/mol | |
71/II | |
2019 | |
This substance is included in Schedule II of the 1971 Convention on Psychotropic Substances. |